• MRSA EVs and RIPA Buffer in OSCC Signaling

  2026-09-30

  MRSA-derived extracellular vesicles are emerging as active signaling agents in oral squamous cell carcinoma rather than passive markers of infection. This article examines how MRSA EVs may engage ERK/c-Jun, IL-8/CXCR1, and JAK/STAT5A signaling, then translates those findings into a practical protein-analysis strategy. It explains where RIPA Lysis Buffer (Medium) supports reproducible cell and tissue lysates, where its detergent strength requires caution, and how translational teams can design stronger validation packages without overstating preclinical evidence.

• LY294002 for PI3K/Akt/mTOR Pathway Experiments

  2026-09-30

  LY294002 enables reversible interrogation of PI3K-dependent survival, apoptosis, and autophagy across cell and animal models. This practical guide connects concentration-controlled pathway inhibition with the MCAO neurobiology workflow used to test PI3K/Akt-dependent axonal regeneration.

• BMP4–GPX4 Protects RGCs in Experimental Glaucoma

  2026-09-29

  The reference study links BMP4 signaling with GPX4-mediated control of ferroptosis in retinal ganglion cells exposed to an NMDA-induced glaucoma model. Its main contribution is a combined neuroprotection and retinal stem cell differentiation framework, although the findings remain preclinical and require validation across injury paradigms and transplantation protocols.

• Dietary Arachidonic Acid and Rapid Vaccine Immunity

  2026-09-29

  The reference study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced humoral immunity in mice and human volunteers. Its key mechanistic contribution is the link between lymph-node lipid metabolism, prostaglandin I2 signaling, and B-cell maturation through the cAMP–PKA axis.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-09-28

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for detecting α-D-glucose and α-D-mannose residues associated with glycoproteins and glycolipids in cells and tissues. It is appropriate for cell surface carbohydrate detection, immunofluorescence staining, and flow cytometry, but it should not be treated as a universal glycan stain or a probe for non-carbohydrate targets.

• KN-62 Workflows for CaMKII Signaling Research

  2026-09-28

  Use KN-62 to probe CaMKII-dependent signaling across secretion, metabolism, and cell-cycle assays—with pilot conditions that distinguish enzyme inhibition from changes in calcium entry. The workflow also places recent social-memory findings in context without implying that the reference study tested KN-62 or established a CaMKII mechanism.

• CA-074: Selective Cathepsin B Inhibitor

  2026-09-27

  CA-074 is a potent cathepsin B inhibitor used to investigate protease-dependent biology, including cancer metastasis, neurotoxicity, and immune response modulation. Its reported nanomolar affinity supports selective target interrogation, but the available product information does not specify assay conditions, so experimental selectivity and activity should be verified in each model.

• GW 6471: PPARα Antagonist Workflows

  2026-09-26

  Use GW 6471 to test whether PPARα activity contributes to lipid remodeling or toxicant-associated liver injury—not merely whether a pathway is enriched. This guide turns zebrafish findings into practical, controlled workflows for cellular metabolism research, with concentration planning and troubleshooting that help distinguish target-linked effects from solvent or general toxicity.

• NMDA for Excitotoxicity and Retinal Injury Models

  2026-09-25

  NMDA offers a direct way to activate NMDA receptors and build controlled excitotoxicity workflows, including calcium influx and oxidative stress assays. A retinal injury study connects NMDA-based modeling with BMP4–GPX4 signaling and ferroptosis readouts, while highlighting why receptor activation alone does not establish a high-intraocular-pressure mechanism.

• AM 281 as a Causal Probe of CB1 Signaling

  2026-09-25

  Explore how AM 281 can help researchers test causal links between CB1 activity, astrocytic glutamate clearance, and cognitive outcomes. This article interprets recent TBI findings through the lens of assay design, evidence boundaries, and reproducible pharmacology.

• Mouse Neutrophil Cell Isolation Kit for mRNA Studies

  2026-09-24

  Connect neutrophil-targeted mRNA nanovaccine findings to a practical workflow for preparing mouse neutrophils from bone marrow, blood, or spleen. Negative selection supports functional assays by leaving the target cells unlabeled, with product-reported purity above 95% and an approximately 30-minute, column-free separation.

• Merbromin Inhibits SARS-CoV-2 3CLpro by Mixed-Type Binding

  2026-09-24

  A high-throughput enzyme screen identified merbromin as a selective in-vitro inhibitor of SARS-CoV-2 3CLpro, with kinetic results consistent with mixed-type inhibition. Binding assays and molecular docking supported a model with two possible binding sites, but the findings establish an enzyme-level lead rather than antiviral efficacy or clinical utility.

• Biomimetic α-Cyperone Nanoparticles Protect KGN Cells

  2026-09-23

  The study reports a macrophage-membrane-coated PLGA nanocomplex carrying α-cyperone and displaying the FSHL81–95 peptide, designed to deliver the poorly water-soluble compound to granulosa cells. In LPS-challenged KGN cells, the formulation reduced inflammatory and oxidative-stress readouts while activating Nrf2/HO-1 signaling and suppressing NF-κB activity, providing cell-model evidence for further investigation—not proof of a treatment for diminished ovarian reserve.

• InstaBlue Protein Stain Solution Protocol

  2026-09-23

  InstaBlue Protein Stain Solution provides rapid Coomassie-based visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suitable for routine protein electrophoresis analysis and workflows that require mass spectrometry compatibility, but it should not replace a validated protein quantification assay or protocols that depend on irreversible fixation.

• TRPV1 and TRPA1: Bifurcated ROS Sensing

  2026-09-22

  A 2026 Redox Biology study shows that TRPV1 and TRPA1 do not respond uniformly to reactive oxygen species: singlet oxygen and hydrogen peroxide engage distinct channel-specific mechanisms. The contrasting effects of Carvacrol and allyl isothiocyanate further show why agonist identity matters when interpreting TRPA1 redox experiments.

8738 records 1/583 page Next 12345 下5页 Last page